Oncology

News

GSK backs £50m Oxford University cancer vaccine programme

A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.

Oncology

Life Sciences Industry Report - Part 5 feature image

Life Sciences Industry Report - Oncology

Developments in the oncology space in 2024 brought hope to both industry and patients.

Oncology

Harnessing IL-12: Immunotherapy research advances may enhanc...

While there have been many significant advances in healthcare in the past 25 years, including new treatments for cancer recurrence, more effective disease maintenance strategies, more preci

News

EU approves endometrial, lung cancer drugs from GSK and J&J

Both GSK and J&J have claimed pivotal approvals for growth-phase oncology therapies in the EU.

News

AZ, Daiichi get FDA nod for Dato-DXd in breast cancer

AstraZeneca and Daiichi Sankyo have claimed FDA approval for a second antibody-drug conjugate for breast cancer - TROP2-directed Datroway.

News

Amgen picks up key colorectal cancer okay for KRAS drug

Can a new FDA approval in colorectal cancer kickstart sales growth for Amgen's KRAS inhibitor Lumakras?

GSK backs £50m Oxford University cancer vaccine programme

Life Sciences Industry Report - Oncology

Harnessing IL-12: Immunotherapy research advances may enhanc...

EU approves endometrial, lung cancer drugs from GSK and J&J

AZ, Daiichi get FDA nod for Dato-DXd in breast cancer

Amgen picks up key colorectal cancer okay for KRAS drug

Grail cancer test gets lukewarm backing from FDA adcomm

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks